Scripps VIVO scripps research logo

  • Index
  • Log in
  • Home
  • People
  • Organizations
  • Research
  • Events
Search form
As of April 1st VIVO Scientific Profiles will no longer updated for faculty, and the link to VIVO will be removed from the library website. Faculty profile pages will continue to be updated via Interfolio. VIVO will continue being used behind the scenes to update graduate student profiles. Please contact helplib@scripps.edu if you have questions.
How to download citations from VIVO | Alternative profile options

The dopamine d3 receptor partial agonist cjb090 and antagonist pg01037 decrease progressive ratio responding for methamphetamine in rats with extended-access

Academic Article
uri icon
  • Overview
  • Research
  • Identity
  • Additional Document Info
  • View All
scroll to property group menus

Overview

authors

  • Orio, L.
  • Wee, Sunmee
  • Newman, A. H.
  • Pulvirenti, Luigi
  • Koob, George

publication date

  • July 2010

journal

  • Addiction Biology  Journal

abstract

  • Previous work suggests a role for dopamine D3-like receptors in psychostimulant reinforcement. The development of new compounds acting selectively at dopamine D3 receptors has opened new possibilities to explore the role of these receptors in animal models of psychostimulant dependence. Here we investigated whether the dopamine D3 partial agonist CJB090 (1-10 mg/kg, i.v) and the D3 antagonist PG01037 (8-32 mg/kg, s.c.) modified methamphetamine (0.05 mg/kg/injection) intravenous self-administration under fixed- (FR) and progressive- (PR) ratio schedules in rats allowed limited (short access, ShA; 1-hour sessions 3 days/week) or extended access (long access, LgA; 6 hour sessions 6 days/week). Under a FR1 schedule, the highest dose of the D3 partial agonist CJB090 selectively reduced methamphetamine self-administration in LgA but not in ShA rats, whereas the full D3 antagonist PG01037 produced no effect in either group. Under a PR schedule of reinforcement, the D3 partial agonist CJB090 reduced the maximum number of responses performed ('breakpoint') for methamphetamine in LgA rats at the doses of 5 and 10 mg/kg, and also it produced a significant reduction in the ShA group at the highest dose. However, the D3 full antagonist PG01037 only reduced PR methamphetamine self-administration in LgA rats at the highest dose of 32 mg/kg with no effect in the ShA group. The results suggest that rats might be more sensitive to pharmacological modulation of dopamine D3 receptors following extended access to methamphetamine self-administration, opening the possibility that D3 receptors play a role in excessive methamphetamine intake.

subject areas

  • Amphetamine-Related Disorders
  • Animals
  • Benzamides
  • Central Nervous System Stimulants
  • Dopamine Agents
  • Dose-Response Relationship, Drug
  • Drug Administration Schedule
  • Infusions, Intravenous
  • Male
  • Methamphetamine
  • Motivation
  • Piperazines
  • Pyridines
  • Rats
  • Rats, Wistar
  • Receptors, Dopamine D3
  • Reinforcement Schedule
  • Self Administration
scroll to property group menus

Research

keywords

  • D(3) receptor
  • dependence
  • dopamine
  • methamphetamine
  • partial agonist
  • self-administration
scroll to property group menus

Identity

PubMed Central ID

  • PMC2903631

International Standard Serial Number (ISSN)

  • 1355-6215

Digital Object Identifier (DOI)

  • 10.1111/j.1369-1600.2010.00211.x

PubMed ID

  • 20456290
scroll to property group menus

Additional Document Info

start page

  • 312

end page

  • 323

volume

  • 15

issue

  • 3

©2022 The Scripps Research Institute | Terms of Use | Powered by VIVO

  • About
  • Contact Us
  • Support